NYSE:TDOCTeladoc Health Stock Price, Forecast & News

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TDOC shares have increased by 61.4% and is now trading at $221.83. View which stocks have been most impacted by Coronavirus.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Teladoc Health.

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Teladoc Health.

Teladoc Health will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Teladoc Health Inc (NYSE:TDOC) posted its earnings results on Wednesday, April, 29th. The health services provider reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.35) by $0.05. The health services provider had revenue of $180.80 million for the quarter, compared to the consensus estimate of $180.64 million. Teladoc Health had a negative net margin of 16.24% and a negative return on equity of 10.60%. The company's quarterly revenue was up 40.6% on a year-over-year basis. During the same quarter last year, the business posted ($0.43) earnings per share. View Teladoc Health's earnings history.

Teladoc Health issued an update on its second quarter 2020 After-Hours earnings guidance on Wednesday, April, 29th. The company provided EPS guidance of -0.28--0.23 for the period, compared to the Thomson Reuters consensus estimate of $-0.3. The company issued revenue guidance of $215-225 million, compared to the consensus revenue estimate of $182.26 million.

27 equities research analysts have issued twelve-month target prices for Teladoc Health's shares. Their forecasts range from $80.00 to $280.00. On average, they anticipate Teladoc Health's share price to reach $176.46 in the next year. This suggests that the stock has a possible downside of 20.5%. View analysts' price targets for Teladoc Health.

Media headlines about TDOC stock have been trending positive on Thursday, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Teladoc Health earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned media stories about the health services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news about Teladoc Health.

Some companies that are related to Teladoc Health include Bayer (BAYN), Illumina (ILMN), Takeda Pharmaceutical (TAK), Humana (HUM), Boston Scientific (BSX), Biogen (BIIB), Edwards Lifesciences (EW), Baxter International (BAX), Siemens Healthineers (SHL), LONZA GRP AG/ADR (LZAGY), DexCom (DXCM), Centene (CNC), RESMED/IDR UNRESTR (RMD), COLOPLAST A/S/ADR (CLPBY) and HCA Healthcare (HCA). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS), Trade Desk (TTD), Square (SQ), salesforce.com (CRM) and Paypal (PYPL).

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Teladoc Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.84%), Scout Investments Inc. (0.14%), Envestnet Asset Management Inc. (0.13%), Spence Asset Management (0.05%), Carnegie Capital Asset Management LLC (0.04%) and Meridian Wealth Management LLC (0.02%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist. View institutional ownership trends for Teladoc Health.

TDOC stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Spence Asset Management, Wesbanco Bank Inc., Gradient Investments LLC, Legacy Capital Partners Inc., Carnegie Capital Asset Management LLC, Buckley Wealth Management LLC, and Teamwork Financial Advisors LLC. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete, and William H Frist. View insider buying and selling activity for Teladoc Health.

TDOC stock was purchased by a variety of institutional investors in the last quarter, including Scout Investments Inc., Secure Asset Management LLC, DNB Asset Management AS, Empowered Funds LLC, IFM Investors Pty Ltd, Wedbush Securities Inc., Meridian Wealth Management LLC, and Envestnet Asset Management Inc.. View insider buying and selling activity for Teladoc Health.

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TDOC stock can currently be purchased for approximately $221.83.

Teladoc Health has a market capitalization of $16.52 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

The official website for Teladoc Health is www.teladoc.com.

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]